Neoadjuvant Study of Pyrotinib in Patients With HER2 Positive Breast Cancer
Conditions: Breast Cancer; Neoplasm, Breast; Breast Diseases Interventions: Drug: Pyrotinib; Drug: Trastuzumab; Drug: Docetaxel; Drug: Carboplatin; Drug: Placebo Oral Tablet Sponsor: Zhejiang Cancer Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | Docetaxel | HER2 | Herceptin | Hospitals | Neoadjuvant Therapy | Study | Taxotere